Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > When is phase III trial going to start?
View:
Post by Bookworm28 on Jun 04, 2021 2:52pm

When is phase III trial going to start?

I see some frustration wrt phase III trials. Last year the Co said Q1 of this year, now I see H2 of this year. The Co also said last year. Seems like they have a habit of hurry up and wait. Is their tech worth the wait? Just looking for opinions. Thanks.
Comment by Bookworm28 on Jun 04, 2021 2:57pm
...sorry, the Co also said last year.... " while at the same time expeditiously moving forward with phase III development. This parallel strategy is important, as partnering outreach and execution are an extensive, involved process, and the continued advancement of the drug's development program is expected to increase market value and negotiating leverage." So phase III ...more  
Comment by MrMugsy on Jun 05, 2021 11:11am
So ... a three pronged approach is the way Dan put it ... 1.  Phase 3 for OTENA. 2.  Drug development program - strengthen IP. 3.  Partnering efforts. And now we know definitively that ATE is focusing on USA, Europe and Japan for partnering (presentation). I would also bet there are a few surprises possible on the drug development side - even partnering on some development ...more  
Comment by Layth1990 on Jun 04, 2021 3:30pm
Let me tell you the truth. Once ph3 starts, we will hit ath for sure. The reasons you have stated are all true and caused frustration for myself as well. If ph3 starts in 2021 i will be more than happy. We still don't have info about about design and dosing. I'm not following closely about toxicology studies and fda response for filling ind , so i have no idea how are they progressing or ...more  
Comment by Bookworm28 on Jun 04, 2021 6:33pm
Thanks Layth1990. I put in a bid, but no bites. Really don't want to miss out on a phase iii rally, but really don't want to be watching the paint dry for the next year. We'll see what next week brings.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities